252 related articles for article (PubMed ID: 3155915)
21. The use of monoclonal antibodies in the diagnosis of peripheral T-cell lymphomas.
Giraldo AA; Higgins MJ; Zielinska E; Humes JJ
Ann Clin Lab Sci; 1987; 17(2):67-73. PubMed ID: 2953297
[TBL] [Abstract][Full Text] [Related]
22. T cells and T-cell subsets in mycosis fungoides and parapsoriasis. A study of 18 cases with anti-human T-cell monoclonal antibodies and histochemical techniques.
Buechner SA; Winkelmann RK; Banks PM
Arch Dermatol; 1984 Jul; 120(7):897-905. PubMed ID: 6233942
[TBL] [Abstract][Full Text] [Related]
23. Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.
Weiss LM; Wood GS; Warnke RA
Am J Pathol; 1985 Aug; 120(2):179-85. PubMed ID: 3161334
[TBL] [Abstract][Full Text] [Related]
24. Expression of Leu-8 antigen, a majority T-cell marker, is uncommon in mycosis fungoides.
Abel EA; Wood GS; Hoppe RT; Warnke RA
J Invest Dermatol; 1985 Sep; 85(3):199-202. PubMed ID: 3161956
[TBL] [Abstract][Full Text] [Related]
25. [Monoclonal antibodies in the study of malignant skin lymphomas].
Trofimova IB; Tupitsyn NN; Sholokhova EN; Kadagidze ZG; Baryshnikov AB
Vestn Dermatol Venerol; 1989; (8):9-14. PubMed ID: 2530727
[TBL] [Abstract][Full Text] [Related]
26. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and immunohistological correlation of malignant lymphomas of the skin.
Giam YC; Ong BH
Ann Acad Med Singap; 1994 May; 23(3):412-7. PubMed ID: 7944261
[TBL] [Abstract][Full Text] [Related]
28. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
Harris NL; Nadler LM; Bhan AK
Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
[TBL] [Abstract][Full Text] [Related]
29. Mycosis fungoides/Sezary's syndrome progressing to immunoblastic sarcoma. A T-cell lymphoproliferation with both helper and suppressor phenotypes.
Yanagihara ET; Parker JW; Meyer PR; Cain MJ; Hofman F; Lukes RJ
Am J Clin Pathol; 1984 Feb; 81(2):249-57. PubMed ID: 6230003
[TBL] [Abstract][Full Text] [Related]
30. T-immunoblastic lymphoma mimicking B-immunoblastic lymphoma.
Swanson S; Innes DJ; Frierson HF; Hess CE
Arch Pathol Lab Med; 1987 Nov; 111(11):1077-80. PubMed ID: 2959240
[TBL] [Abstract][Full Text] [Related]
31. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens.
Kadin M; Nasu K; Sako D; Said J; Vonderheid E
Am J Pathol; 1985 May; 119(2):315-25. PubMed ID: 3158209
[TBL] [Abstract][Full Text] [Related]
32. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
Cossman J; Jaffe ES; Fisher RI
Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
[TBL] [Abstract][Full Text] [Related]
33. Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes.
Grogan TM; Fielder K; Rangel C; Jolley CJ; Wirt DP; Hicks MJ; Miller TP; Brooks R; Greenberg B; Jones S
Am J Clin Pathol; 1985 Mar; 83(3):279-88. PubMed ID: 2983525
[TBL] [Abstract][Full Text] [Related]
34. Peripheral T-cell lymphoma with helper T-cell phenotype (Leu 3a+ Leu 8-).
Segami H; Abe M; Wakasa H
Acta Pathol Jpn; 1988 May; 38(5):591-603. PubMed ID: 2975137
[TBL] [Abstract][Full Text] [Related]
35. The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides.
Wood GS; Burke JS; Horning S; Doggett RS; Levy R; Warnke RA
Blood; 1983 Aug; 62(2):464-72. PubMed ID: 6603242
[TBL] [Abstract][Full Text] [Related]
36. Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases.
Knowles DM; Halper JP
Am J Pathol; 1982 Feb; 106(2):187-203. PubMed ID: 6978074
[TBL] [Abstract][Full Text] [Related]
37. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia.
Weiss LM; Bindl JM; Picozzi VJ; Link MP; Warnke RA
Blood; 1986 Feb; 67(2):474-8. PubMed ID: 3080041
[TBL] [Abstract][Full Text] [Related]
38. Expression of the Leu-8 antigen by B-cell lymphomas.
Michie SA; Garcia CF; Strickler JG; Dailey MO; Rouse RV; Warnke RA
Am J Clin Pathol; 1987 Oct; 88(4):486-90. PubMed ID: 3310610
[TBL] [Abstract][Full Text] [Related]
39. The intracutaneous growth of murine lymphomas: epidermal invasion is characteristic of multiple tumor phenotypes.
Piepkorn M; Tigelaar RE
J Invest Dermatol; 1984 Oct; 83(4):281-5. PubMed ID: 6237158
[TBL] [Abstract][Full Text] [Related]
40. Immunologic methods in cytology: definitive diagnosis of non-Hodgkin's lymphomas using immunologic markers for T- and B-cells.
Martin SE; Zhang HZ; Magyarosy E; Jaffe ES; Hsu SM; Chu EW
Am J Clin Pathol; 1984 Dec; 82(6):666-73. PubMed ID: 6391148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
